Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 384
Filtrar
1.
Nature ; 627(8004): 612-619, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38480877

RESUMO

Less than 30% of people in Africa received a dose of the COVID-19 vaccine even 18 months after vaccine development1. Here, motivated by the observation that residents of remote, rural areas of Sierra Leone faced severe access difficulties2, we conducted an intervention with last-mile delivery of doses and health professionals to the most inaccessible areas, along with community mobilization. A cluster randomized controlled trial in 150 communities showed that this intervention with mobile vaccination teams increased the immunization rate by about 26 percentage points within 48-72 h. Moreover, auxiliary populations visited our community vaccination points, which more than doubled the number of inoculations administered. The additional people vaccinated per intervention site translated to an implementation cost of US $33 per person vaccinated. Transportation to reach remote villages accounted for a large share of total intervention costs. Therefore, bundling multiple maternal and child health interventions in the same visit would further reduce costs per person treated. Current research on vaccine delivery maintains a large focus on individual behavioural issues such as hesitancy. Our study demonstrates that prioritizing mobile services to overcome access difficulties faced by remote populations in developing countries can generate increased returns in terms of uptake of health services3.


Assuntos
Vacinas contra COVID-19 , Serviços de Saúde Comunitária , Vacinação em Massa , Unidades Móveis de Saúde , Serviços de Saúde Rural , Cobertura Vacinal , Criança , Humanos , Serviços de Saúde Comunitária/métodos , Serviços de Saúde Comunitária/organização & administração , COVID-19/prevenção & controle , Vacinas contra COVID-19/administração & dosagem , Vacinas contra COVID-19/economia , Vacinas contra COVID-19/provisão & distribuição , Unidades Móveis de Saúde/organização & administração , Serviços de Saúde Rural/organização & administração , Serra Leoa , Meios de Transporte/economia , Cobertura Vacinal/economia , Cobertura Vacinal/métodos , Cobertura Vacinal/estatística & dados numéricos , Hesitação Vacinal , Vacinação em Massa/métodos , Vacinação em Massa/organização & administração , Feminino , Adulto , Mães
2.
BMJ Glob Health ; 8(11)2023 11 30.
Artigo em Inglês | MEDLINE | ID: mdl-38035734

RESUMO

This article aims to propose practical solutions that coordinate the conflicting interests between the global community and the pharmaceutical industry on the intellectual property (IP) waiver for COVID-19 vaccines and facilitate a more equitable vaccine supply chain in the post-COVID-19 world. We critically conducted a narrative literature review to identify procedural and practical issues in the current vaccine supply chain. The search was conducted across various academic disciplines, including biomedical science, life science, law and social science, using resources such as PubMed, Web of Science, Scopus and Westlaw. After screening 731 articles, 55 studies were selected for review. The narrative review revealed several critical barriers that hinder vaccine supply in less-developed countries (LDCs) as follows: (1) WTO Trade-Related Aspects of Intellectual Property Rights (TRIPs) waiver requests may not be granted due to its stringent consensus rule; (2) the current compulsory license system may not work due to the complexity of IP rights covering COVID-19 vaccine technologies; (3) only a few LDCs have domestic companies capable of manufacturing vaccines, and (4) political and economic tensions among countries exacerbate existing barriers to vaccine distribution in LDCs. Based on these findings, we proposed a comprehensive compulsory license system, which combines TRIPS's compulsory license system with the third-party beneficiary mechanism under Common Law. This integrated approach offers a balanced solution that ensures fair compensation for vaccine developers while facilitating broader vaccine access.


Assuntos
COVID-19 , Vacinas , Humanos , COVID-19/prevenção & controle , Vacinas contra COVID-19/provisão & distribuição , Propriedade Intelectual , Cooperação Internacional
7.
Med Educ Online ; 28(1): 2241169, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37499134

RESUMO

The current healthcare system disproportionately affects vulnerable populations, leading to disparities in health outcomes. As a result, medical schools need to equip future physicians with the tools to identify and address healthcare disparities. The University of Nevada, Reno School of Medicine implemented a Scholarly Concentration in Medical Social Justice (SCiMSJ) program to address this issue. Three medical students joined the program and pioneered a project to address the equitable vaccine distribution within the local Hispanic/Latinx community. After identifying the disparity in vaccine uptake and high levels of vaccine hesitancy, they collaborated with local organizations to address vaccine misinformation and accessibility. They organized outreach events, provided vaccine education, and hosted a vaccine clinic at a Catholic church with a high Hispanic/Latinx congregation. Through their efforts, they administered 1,456 vaccines. The estimated economic and societal impacts of their work was 879 COVID-19 cases avoided, 5 deaths avoided, 45 life years saved, and $29,286 in economic value. The project's success highlights the effectiveness of a student-led approach to promote skill development in social justice training. Leadership skills and coalition building were crucial in overcoming resource limitations and connecting organizations with the necessary volunteer force. Building trust with the Hispanic/Latinx community through outreach efforts and addressing vaccine hesitancy contributed to the well-attended vaccine clinic. The project's framework and approach can be adopted by other medical students and organizations to address health disparities and improve health outcomes in their communities.


Assuntos
Vacinas contra COVID-19 , COVID-19 , Educação Médica , Equidade em Saúde , Disparidades em Assistência à Saúde , Justiça Social , Estudantes de Medicina , Humanos , COVID-19/prevenção & controle , Vacinas contra COVID-19/provisão & distribuição , Vacinas contra COVID-19/uso terapêutico , Educação Médica/organização & administração , Educação Médica/normas , Hispânico ou Latino , Justiça Social/educação , Equidade em Saúde/organização & administração , Disparidades em Assistência à Saúde/etnologia , Disparidades em Assistência à Saúde/organização & administração
11.
J Racial Ethn Health Disparities ; 10(4): 1597-1604, 2023 08.
Artigo em Inglês | MEDLINE | ID: mdl-35689156

RESUMO

Black Americans are more likely to be essential workers due to racial capitalism. Because of the COVID-19 pandemic, essential workers are less able to adhere to social distancing and stay-at-home guidelines due to the nature of their work, because they are more likely to occupy crowded households, and are more likely to possess pre-existing health conditions. To assist Black essential workers in preventing infection or reducing the intensity of symptoms if contracted, vaccination against the virus is essential. Unfortunately, Black essential workers face considerable barriers to accessing vaccinations and are hesitant to receive the vaccine due to widespread misinformation and justified historical mistrust of the American medical system. The purpose of this work is to (1) describe the disproportionate impact of COVID-19 on Black essential workers due to racial capitalism, (2) outline the socioeconomic and racial barriers related to vaccination within this population, and (3) to suggest policy-related approaches to facilitate vaccination such as access to on-site vaccination opportunities, the funding of community outreach efforts, and the mandating of increased employee benefits.


Assuntos
População Negra , COVID-19 , Capitalismo , Controle de Doenças Transmissíveis , Equidade em Saúde , Racismo Sistêmico , Humanos , COVID-19/economia , COVID-19/epidemiologia , COVID-19/etnologia , COVID-19/prevenção & controle , Pandemias/economia , Políticas , Política de Saúde/economia , Vacinas contra COVID-19/economia , Vacinas contra COVID-19/provisão & distribuição , Acesso aos Serviços de Saúde/economia , Equidade em Saúde/economia , Racismo Sistêmico/economia , Racismo Sistêmico/etnologia , Controle de Doenças Transmissíveis/economia , Controle de Doenças Transmissíveis/métodos
12.
Rev. Cient. Esc. Estadual Saúde Pública de Goiás Cândido Santiago ; 9 (Ed. Especial, 1ª Oficina de Elaboração de Pareceres Técnicos Científicos (PTC): 9f2-EE3, 2023. graf, tab
Artigo em Português | LILACS, CONASS, Coleciona SUS, SES-GO | ID: biblio-1525095

RESUMO

Este protocolo teve como objetivo estruturar as etapas de elaboração de um Scoping Review que pretende estudar as experiências de desenvolvimento e produção de vacinas em 5 países selecionados, comparando com o Brasil. Sendo assim, a introdução buscou contextualizar a questão de desenvolvimento e produção de vacinas no mundo. Posteriormente, foi apresentado o método do trabalho que, neste caso perpassa por uma explanação da escolha prévia dos 5 países selecionados, além de uma busca em 5 repositórios, seguida de busca manual. A pergunta de pesquisa e as palavras chaves foram apresentadas em conjunto com descrição dos critérios de inclusão e exclusão, que levaram a uma seleção final de 25 documentos completos. Por fim, foram apresentados os resultados esperados, quanto ao que se espera encontrar na análise de atores e ações realizadas nos países investigados


This protocol aimed to structure the steps of a Scoping Review that intends to study the experiences of vaccine development and production in 5 selected countries, comparing with Brazil. Thus, the introduction sought to contextualize the issue of vaccine development and production in the world. Afterwards, the method of the work was presented, which in this case involves an explanation of the previous choice of the 5 selected countries, besides a search in 5 repositories, followed by a manual search. The research question and the key words were presented together with a narrative of the inclusion and exclusion criteria, which led to a total selection of 25 full documents. Finally, the expected results were presented, which indicates what is expected to be found in the analysis of actors and actions taken in the countries in question


Assuntos
Humanos , Masculino , Feminino , Gastos em Pesquisa , Vacinas contra COVID-19/provisão & distribuição , Desenvolvimento de Vacinas , Estados Unidos , Brasil , China , Federação Russa , Reino Unido
14.
West J Emerg Med ; 23(4): 570-578, 2022 Jul 11.
Artigo em Inglês | MEDLINE | ID: mdl-35980411

RESUMO

INTRODUCTION: Unvaccinated emergency medical services (EMS) personnel are at increased risk of contracting coronavirus disease 2019 (COVID-19) and potentially transmitting the virus to their families, coworkers, and patients. Effective vaccines for the severe acute respiratory syndrome coronavirus 2 virus exist; however, vaccination rates among EMS professionals remain largely unknown. Consequently, we sought to document vaccination rates of EMS professionals and identify predictors of vaccination uptake. METHODS: We conducted a cross-sectional survey of North Carolina EMS professionals after the COVID-19 vaccines were widely available. The survey assessed vaccination status as well as beliefs regarding COVID-19 illness and vaccine effectiveness. Prediction of vaccine uptake was modeled using logistic regression. RESULTS: A total of 860 EMS professionals completed the survey, of whom 74.7% reported receiving the COVID-19 vaccination. Most respondents believed that COVID-19 is a serious threat to the population, that they are personally at higher risk of infection, that vaccine side effects are outweighed by illness prevention, and the vaccine is safe and effective. Despite this, only 18.7% supported mandatory vaccination for EMS professionals. Statistically significant differences were observed between the vaccinated and unvaccinated groups regarding vaccine safety and effectiveness, recall of employer vaccine recommendation, perceived risk of infection, degree of threat to the population, and trust in government to take actions to limit the spread of disease. Unvaccinated respondents cited reasons such as belief in personal health and natural immunity as protectors against infection, concerns about vaccine safety and effectiveness, inadequate vaccine knowledge, and lack of an employer mandate for declining the vaccine. Predictors of vaccination included belief in vaccine safety (odds ratio [OR] 5.5, P=<0.001) and effectiveness (OR 4.6, P=<0.001); importance of vaccination to protect patients (OR 15.5, P=<0.001); perceived personal risk of infection (OR 1.8, P=0.04); previous receipt of influenza vaccine (OR 2.5, P=0.003); and sufficient knowledge to make an informed decision about vaccination (OR 2.4, P=0.024). CONCLUSION: In this survey of EMS professionals, over a quarter remained unvaccinated for COVID-19. Given the identified predictors of vaccine acceptance, EMS systems should focus on countering misinformation through employee educational campaigns as well as on developing policies regarding workforce immunization requirements.


Assuntos
Vacinas contra COVID-19 , COVID-19 , Serviços Médicos de Emergência , Pessoal de Saúde , Vacinação , COVID-19/prevenção & controle , Vacinas contra COVID-19/administração & dosagem , Vacinas contra COVID-19/efeitos adversos , Vacinas contra COVID-19/provisão & distribuição , Estudos Transversais , Tomada de Decisões , Pessoal de Saúde/psicologia , Pessoal de Saúde/estatística & dados numéricos , Inquéritos Epidemiológicos , Humanos , Vacinas contra Influenza/administração & dosagem , North Carolina , Saúde Ocupacional , Segurança do Paciente , Vacinação/legislação & jurisprudência , Vacinação/psicologia , Vacinação/estatística & dados numéricos
15.
Int J Equity Health ; 21(1): 122, 2022 08 30.
Artigo em Inglês | MEDLINE | ID: mdl-36042485

RESUMO

BACKGROUND: The equality in the distribution of vaccines between and within countries along with follow sanitation tips and observe social distance, are effective strategies to rid the world of COVID-19 pandemic. Inequality in the distribution of COVID-19 vaccine, in addition to causing inequity to the population health, has a significant impact on the process of economic recovery. METHODS: All published original papers on the inequality of Covid-19 vaccine distribution and the factors affecting it were searched in PubMed, Web of Science, Scopus and ProQuest databases between December 2020 to 30 May 2022. Selection of articles, extraction of their data and qualitative assessment (by STROBE) were performed by two researchers separately. Data graphing form was used to extract detailed data from each study and then, the collected data were classified. RESULTS: A total of 4623 articles were evaluated. After removing duplicates and screening the title, abstract and full text of articles, 22 articles were selected and entered into the study. Fifteen (68.17%) studies were conducted in the United States, three (13.64%) in Europe, three (13.64%) in Asia and one (6.66%) in Oceania. Factors affecting the inequality in the distribution of COVID-19 vaccine were classified into macro and micro levels determinants. CONCLUSION: Macro determinants of inequality in the Covid-19 vaccine distribution were consisted of economic (stability and country's economic status, Gross Domestic Product (GDP) per capita, financial support and human development index), infrastructure and health system (appropriate information system, functional cold chains in vaccine transport, transport infrastructure, medical and non-medical facilities per capita, healthcare access and quality), legal and politics (vaccination allocation rules, health policies, political ideology and racial bias), and epidemiologic and demographic factors (Covid-19 incidence and deaths rate, life expectancy, vulnerability to Covid-19, working in medical setting, comorbidities, social vulnerability, incarceration and education index). Moreover, micro/ individual level factors were included in economic (household's income, home ownership, employment, poverty, access to healthy food and residency in the deprived areas) and demographic and social characteristics (sex, age, race, ethnic, religion, disability, location (urban/rural) and insurance coverage).


Assuntos
Vacinas contra COVID-19 , COVID-19 , Disparidades em Assistência à Saúde , Ásia , COVID-19/epidemiologia , COVID-19/prevenção & controle , Vacinas contra COVID-19/provisão & distribuição , Demografia , Europa (Continente) , Disparidades em Assistência à Saúde/estatística & dados numéricos , Humanos , Oceania , Fatores Socioeconômicos , Estados Unidos
16.
Atlanta; Centers for Disease Control and Prevention; rev; July 28, 2022. 3 p.
Não convencional em Inglês | BIGG - guias GRADE | ID: biblio-1396382

RESUMO

The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).


Assuntos
Programas de Imunização/normas , Centers for Disease Control and Prevention, U.S. , Vacinas contra COVID-19/provisão & distribuição , COVID-19/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...